Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation

Bone Marrow Transplant. 2010 Apr;45(4):798-800. doi: 10.1038/bmt.2009.231. Epub 2009 Sep 7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Neoplasm, Residual / genetics
  • Primary Myelofibrosis / genetics
  • Primary Myelofibrosis / therapy*
  • Receptors, Thrombopoietin / genetics
  • Thrombocythemia, Essential / genetics
  • Thrombocythemia, Essential / therapy*
  • Transplantation Chimera
  • Transplantation, Homologous

Substances

  • Receptors, Thrombopoietin
  • MPL protein, human